Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager

Ascendis Pharma A/S

NASDAQ:ASND

Watchlist

Dividends

Price: 137.25 USD 0.64%

Market Cap: 8.2B USD

Have any thoughts about
Ascendis Pharma A/S?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 137.25 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ASND Alert

Ascendis Pharma A/S

137.25

+0.87 (+0.64%)

52 Week Range	112.93 159.4
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Ascendis Pharma A/S

What unique competitive advantages
does Ascendis Pharma A/S hold over its rivals?

What risks and challenges
does Ascendis Pharma A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Ascendis Pharma A/S.

What unique competitive advantages
does Ascendis Pharma A/S hold over its rivals?

What risks and challenges
does Ascendis Pharma A/S face in the near future?

Summarize the latest earnings call
of Ascendis Pharma A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Ascendis Pharma A/S.

Provide P/S
for Ascendis Pharma A/S.

Provide P/E
for Ascendis Pharma A/S.

Provide P/OCF
for Ascendis Pharma A/S.

Provide P/FCFE
for Ascendis Pharma A/S.

Provide P/B
for Ascendis Pharma A/S.

Provide EV/S
for Ascendis Pharma A/S.

Provide EV/GP
for Ascendis Pharma A/S.

Provide EV/EBITDA
for Ascendis Pharma A/S.

Provide EV/EBIT
for Ascendis Pharma A/S.

Provide EV/OCF
for Ascendis Pharma A/S.

Provide EV/FCFF
for Ascendis Pharma A/S.

Provide EV/IC
for Ascendis Pharma A/S.

Show me price targets
for Ascendis Pharma A/S made by professional analysts.

What are the Revenue projections
for Ascendis Pharma A/S?

How accurate were the past Revenue estimates
for Ascendis Pharma A/S?

What are the Net Income projections
for Ascendis Pharma A/S?

How accurate were the past Net Income estimates
for Ascendis Pharma A/S?

What are the EPS projections
for Ascendis Pharma A/S?

How accurate were the past EPS estimates
for Ascendis Pharma A/S?

What are the EBIT projections
for Ascendis Pharma A/S?

How accurate were the past EBIT estimates
for Ascendis Pharma A/S?

Compare the revenue forecasts
for Ascendis Pharma A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Ascendis Pharma A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Ascendis Pharma A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Ascendis Pharma A/S compared to its peers.

Compare the P/E ratios
of Ascendis Pharma A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Ascendis Pharma A/S with its peers.

Analyze the financial leverage
of Ascendis Pharma A/S compared to its main competitors.

Show all profitability ratios
for Ascendis Pharma A/S.

Provide ROE
for Ascendis Pharma A/S.

Provide ROA
for Ascendis Pharma A/S.

Provide ROIC
for Ascendis Pharma A/S.

Provide ROCE
for Ascendis Pharma A/S.

Provide Gross Margin
for Ascendis Pharma A/S.

Provide Operating Margin
for Ascendis Pharma A/S.

Provide Net Margin
for Ascendis Pharma A/S.

Provide FCF Margin
for Ascendis Pharma A/S.

Show all solvency ratios
for Ascendis Pharma A/S.

Provide D/E Ratio
for Ascendis Pharma A/S.

Provide D/A Ratio
for Ascendis Pharma A/S.

Provide Interest Coverage Ratio
for Ascendis Pharma A/S.

Provide Altman Z-Score Ratio
for Ascendis Pharma A/S.

Provide Quick Ratio
for Ascendis Pharma A/S.

Provide Current Ratio
for Ascendis Pharma A/S.

Provide Cash Ratio
for Ascendis Pharma A/S.

What is the historical Revenue growth
over the last 5 years for Ascendis Pharma A/S?

What is the historical Net Income growth
over the last 5 years for Ascendis Pharma A/S?

What is the current Free Cash Flow
of Ascendis Pharma A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Ascendis Pharma A/S.

P/S
Price to Sales

24.4

Current

58.1

Median

7.6

Industry

Lower than median

Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S

24.4

Market Cap

8.3B USD

Revenue

327.4m EUR

All Countries

Forward Multiples

			Market Cap	P/S
DK		Ascendis Pharma A/S NASDAQ:ASND	8.3B USD	24.4
FR		Pharnext SCA OTC:PNEXF	6T USD	38 027 714.7
US		Abbvie Inc NYSE:ABBV	310.2B USD	5.6
US		Amgen Inc NASDAQ:AMGN	142B USD	4.4
US		Gilead Sciences Inc NASDAQ:GILD	115B USD	4.1
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	101.6B USD	9.5
US	E	Epizyme Inc F:EPE	94.1B EUR	1 852.6
AU		CSL Ltd ASX:CSL	134.4B AUD	5.7
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	78.5B USD	5.6
US	S	Seagen Inc F:SGT	39.3B EUR	17.8
NL		argenx SE XBRU:ARGX	36B EUR	19.3

				Revenue Growth	P/S to Growth
DK		Ascendis Pharma A/S NASDAQ:ASND	Average P/S: 3 457 242.1 24.4	260%	0.1
FR		Pharnext SCA OTC:PNEXF	38 027 714.7	N/A	N/A
US		Abbvie Inc NYSE:ABBV	5.6	20%	0.3
US		Amgen Inc NASDAQ:AMGN	4.4	26%	0.2
US		Gilead Sciences Inc NASDAQ:GILD	4.1	10%	0.4
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	9.5	34%	0.3
US	E	Epizyme Inc F:EPE	1 852.6	N/A	N/A
AU		CSL Ltd ASX:CSL	5.7	23%	0.2
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	5.6	23%	0.2
US	S	Seagen Inc F:SGT	17.8	118%	0.2
NL		argenx SE XBRU:ARGX	19.3	220%	0.1

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/S

27.2

2-Years Forward

P/S

15.1

3-Years Forward

P/S

8.3

	Franklin Covey Co NYSE:FC	36.603 USD 0.53%
	Mohawk Industries Inc NYSE:MHK	119.2 USD 0.03%
	Ardmore Shipping Corp NYSE:ASC	11.76 USD 3.98%
	ASGN Inc NYSE:ASGN	83.34 USD -0.63%
	Skyworks Solutions Inc NASDAQ:SWKS	88.94 USD 0.21%
	Weatherford International PLC NASDAQ:WFRD	68.08 USD 1.46%

	Johnson & Johnson NYSE:JNJ	143.8 USD -0.46%
	Bank of America Corp NYSE:BAC	43.7 USD -1.06%
	Mastercard Inc NYSE:MA	522.28 USD -1.09%
	Salesforce Inc NYSE:CRM	338.3925 USD -1.53%
	Abbvie Inc NYSE:ABBV	175.23 USD -0.2%
	Home Depot Inc NYSE:HD	389.215 USD -0.86%

	Arista Networks Inc NYSE:ANET	112.455 USD -0.31%
	Visa Inc NYSE:V	313.87 USD -1.21%
	Texas Pacific Land Corp NYSE:TPL	1 111.11 USD -1.94%
	KLA Corp NASDAQ:KLAC	632.7666 USD 0.54%
	Manhattan Associates Inc NASDAQ:MANH	276.65 USD -1.29%
	Pinduoduo Inc NASDAQ:PDD	99.4179 USD -0.09%

	Salesforce Inc NYSE:CRM	338.3925 USD -1.53%
	Accenture PLC NYSE:ACN	358.36 USD -2.19%
	ServiceNow Inc NYSE:NOW	1 079.65 USD -1.06%
	EOG Resources Inc NYSE:EOG	118.84 USD -0.17%
	Copart Inc NASDAQ:CPRT	57.88 USD -0.58%
	Applied Materials Inc NASDAQ:AMAT	164.88 USD 0.79%

Ascendis Pharma A/S
NASDAQ:ASND

P/S
Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Ascendis Pharma A/S NASDAQ:ASND

P/S Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Ascendis Pharma A/S
NASDAQ:ASND

P/S
Price to Sales